Systems, devices, and formulations for time-phased histamine delivery
AssigneeAgoneX Biopharmaceuticals, Inc.
InventorsCristian Arnou, Neil Flanzraich
Life of this patent
Estimating the term…
Loading patent…
AssigneeAgoneX Biopharmaceuticals, Inc.
InventorsCristian Arnou, Neil Flanzraich
Estimating the term…
Aspects of the disclosure provided herein relate to compositions and methods for providing a drug delivery through a transdermal patch. Some other embodiments relate to a transdermal drug delivery patch comprising a bottom layer comprising a skin side liner, a middle layer comprising a gel, a top layer comprising a release liner, wherein the adhesive or gel comprises at least one drug capable of modulating histamine in a subject. Some other embodiments provided herein relate to a transdermal drug delivery system for delivery of at least one drug into a tissue membrane of a subject. Some other embodiments relate to a transdermal drug delivery patch comprising a bottom layer comprising a skin side liner, a middle layer comprising a gel/adhesive, a top layer comprising a release liner, wherein the gel comprises at least one drug capable of modulating histamine receptors in a subject.
A patch for delivering an active agent to a subject in need thereof, comprising:
A transdermal drug delivery system for delivering at least one drug into a tissue membrane of a subject, the system comprising:
A transdermal drug delivery system for delivering at least one drug into a tissue membrane of a subject, the system comprising:
Dependencies are inferred from the claim text.